My team and I partner with families to develop an individualized treatment plan for each patient that best fits them, their goals and the family’s needs.
Christopher Towe, MD

About

Biography

As a child with allergies and asthma, I always wanted to work with children who had trouble breathing. I’m a board-certified pediatric pulmonologist and director of the Rare Lung Disease Program at Cincinnati Children’s Hospital Medical Center. I see children from all over the country and around the world with unknown or poorly understood lung conditions.

Conditions I treat include:

  • Ultra-rare or undiagnosed childhood interstitial lung diseases
  • Lung graft versus host disease after bone marrow transplant
  • Lung disease caused by other rare systemic diseases such as:
    • Immune deficiencies
    • Autoimmune diseases
    • Auto-inflammatory diseases
    • Lymphatic and other vascular malformations
    • Hereditary hemorrhagic telangiectasia

I perform flexible bronchoscopy, including targeted transbronchial biopsies. I’m one of the few pediatric pulmonologists in the world who regularly performs whole lung lavages (a therapeutic procedure) in children with pulmonary alveolar proteinosis (rare lung disorder).

Even in patients with a known diagnosis, there is often not a well-defined treatment plan. My team and I partner with families to develop an individualized treatment plan for each patient that best fits them, their goals and the family’s needs. I work with a multidisciplinary team, including a dedicated nurse, dietician and respiratory therapist. I often see patients in conjunction with other specialists, such as immunologists, bone marrow transplant specialists and rheumatologists. My colleagues and I often see a patient during the same clinic visit to develop a comprehensive care plan for each patient.

My primary research interest is to improve the characterization, early identification and treatment of pulmonary injury caused by the immune system to improve patient outcomes. My two current areas of focus are:

  • Improving early detection of lung disease following bone marrow transplantation
  • Improving our overall understanding of the cause of lung disease in children with systemic juvenile idiopathic arthritis, preventing these complications from occurring and better treating them when they do

I am unable to study in-depth all the diseases I clinically manage. But, I believe all of my patients and families deserve access to the benefits and promise of research. Therefore, I also facilitate partnerships with other researchers, including many basic scientists, and provide the clinical support needed to facilitate the translational study of these rare pulmonary diseases. This research often happens through n = 1 studies, which involve only one patient or family.

When I’m not seeing patients or involved in research, I enjoy spending time with my family, traveling the world and training for marathons. My wife and I have twice been awarded the President of the United States Volunteer Service Award for our work hosting foreign exchange students — one from Albania and another from Thailand. I grew up in a suburb of Houston, Texas and have a degree in Mechanical Engineering, so if I weren't a doctor, my dream job would be working for NASA and the space program.

MD: University of Texas Southwestern School of Medicine, Dallas, TX, 2008.

Residency: Pediatrics, St. Louis Children's Hospital, St. Louis, MO, 2011.

Fellowship: Pediatric Pulmonary, Washington University School of Medicine, St. Louis, MO, 2014.

Certification: Pediatric Pulmonary, 2014; Pediatrics, 2012.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Community respiratory viruses are generally welltolerated in hematopoietic stem cell transplant recipients: a brief report from the TRANSPIRE study. Haney, M; Ashraf, A; Lake, KE; Strecker, L; Myers, KC; Towe, C; Walkup, L; Woods, J; Edwards, SL; Cooper, R; Goldfarb, SB; Davies, SM; Koo, J; Groups, T. Haematologica: the hematology journal. 2025; 110:1882-1886.

High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE Study. Koo, J; Cooper, R; Edwards, SL; Lane, A; Loveless, SK; Strecker, L; Lake, KE; Myers, KC; Towe, C; Patti, J; Li, M; Goldfarb, SB; Woods, JC; Davies, SM. Pediatric Blood and Cancer. 2025; e31916.

Home Spirometry for Early Identification of Pulmonary Dysfunction After Hematopoietic Stem Cell Transplant in the Transpire Research Study. Urrego, F; Stevens, C; Myers, K; Josephson, M; Silva Carmona, MD J; Gaffin, JM; Abts, MF; Koo, J; Wong, W; Towe, C; Allen, JL; Davies, SM; Goldfarb, SB. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a7235.

Intrabreath Oscillometry (IBO) vs. Spectral Oscillometry (SO) in Detecting Respiratory Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT). Josephson, M; Boas, H; Freedman, J; Young, LR; Goldfarb, SB; Robinson, PD; Towe, C; Gaffin, JM; Wong, W; Koo, J; Lane, A; Davies, SM; Mc Donough, J; Allen, JL. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a5118.

Experience with T Cell–Depleted Allogeneic HSCT for Refractory sJIA Associated with Lung Disease. Cook, E; Schulert, G; Grom, A; Towe, C; Burg, G; Marsh, R; Chandra, S. 2025; 1.

Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. Matt, MG; Drozdov, D; Bendstrup, E; Glerup, M; Hauge, EM; Masmas, T; Schneider, EC; Zeilhofer, UB; Abu-Arja, RF; Driest, KD; Chandra, S; Grom, A; Schulert, GS; Marsh, RA. The Lancet. Rheumatology. 2025; 7:e243-e251.

Frequent Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Brief Transpire Report. Ashraf, A; Lake, KE; Myers, KC; Towe, C; Cooper, R; Edwards, MS L; Hils, B; Davies, SM; Koo, DJ. Transplantation and Cellular Therapy. 2025; 31:s149-s150.

Managing Diffuse Alveolar Hemorrhage in Pediatric HSCT with Inhaled and Intrabronchial Therapy: A Case Series of Targeted Hemostatic Intervention. Grassia, KL; Diseroad, E; Jodele, S; Dandoy, DC E; Towe, C; Davies, SM; Sabulski, DA. Transplantation and Cellular Therapy. 2025; 31:s153.

Cone-Beam CT Imaging for Transbronchial Biopsies in Children. Bozkanat, KM; Towe, C; Burg, G; Hayes, D; Racadio, J; Cabatingan, K; Wallingford, A; Hysinger, E. 2025; 5:13-16.

Xe Ventilation and Gas-Exchange MRI Abnormalities in Children with Neuroendocrine Cell Hyperplasia of Infancy (NEHI). Anderson, MA; Masokano, BI; Plummer, JW; Willmering, MM; Krivchenia, K; Towe, CT; Walkup, LL. Pediatric Pulmonology. 2025; 60:e27410.

From the Blog

Rare Childhood Disease Needs Awareness
Blog Rare and Complex Conditions

Rare Childhood Disease Needs Awareness: Interstitial Lung Disease

By Christopher Towe, MD2/27/2015

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...